Chromogenic in situ hybridisation (CISH) should be an accepted method in the routine diagnostic evaluation of HER2 status in breast cancer

✍ Scribed by Di Palma, S; Collins, N; Faulkes, C; Ping, B; Ferns, G; Haagsma, B; Layer, G; Kissin, M W; Cook, M G

• Book ID: 123610134
• Publisher: BMJ Publishing Group
• Year: 2006
• Tongue: English
• Weight: 260 KB
• Volume: 60
• Category: Article
• ISSN: 0021-9746
• DOI: 10.1136/jcp.2006.043356